Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02984176Phase 4Completed
Phase 4, randomised trial of simethicone in abdominal bloating and flatulence, sponsored by Woman's Health University Hospital. Primary endpoints: Overall exposure of the surgical field at 1 hour and Postoperative pain at 24 hours. Started Aug 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02984176.